Andere Sprachen Prothena Corporation plc

Aktien

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 24.05.2024			% 5 Tage	% 1. Jan.
20,04 ^USD	-0,30 %		-11,01 %	-44,85 %

09.05.	PROTHENA CORPORATION PLC : RBC Capital Markets klebt neutral	ZM
08.05.	Prothena Corporation plc meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI

Prothena: Q1 Earnings Snapshot	08.05.
Prothena : Corporate Overview	08.05.
Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000	08.05.
Prothena Reports First Quarter 2024 Financial Results and Business Highlights	08.05.
Prothena Corporation plc Reports Earnings Results for the First Quarter Ended March 31, 2024	08.05.
Prothena to Report First Quarter 2024 Financial Results on May 8	01.05.
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia and Lymphoma	16.04.
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma	15.04.
Prothena : Director's Report and Financial Statements for Fiscal Year 2023	29.03.
Prothena to Participate in Upcoming Healthcare Conferences	05.03.
Prothena Names David Ford as Chief People Officer	04.03.
Prothena Appoints David Ford to Newly Created Chief People Officer Position	04.03.
Prothena Appoints David Ford to Newly Created Chief People Officer	04.03.
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate	21.02.
Prothena Corporation plc Announces Board Changes	21.02.
Sector Update: Health Care Stocks Gain Pre-Bell Friday	16.02.
Prothena Posts Q4 Net Loss as Revenue Slumps	15.02.
Prothena: Q4 Earnings Snapshot	15.02.
Earnings Flash (PRTA) PROTHENA CORPORATION Reports Q4 Revenue $316,000, vs. Street Est of $2.72M	15.02.
Prothena Corporation plc Provides Earnings Guidance for the Year 2024	15.02.

Keine Ergebnisse zu dieser Suche